Antibiofilm and Antivirulence Properties of 6-Polyaminosteroid Derivatives against Antibiotic-Resistant Bacteria.
Delphine VergozHung LeBenoit BernayAnnick SchaumannMagalie BarreauFlore NillyFlorie DesriacAli TahriouiJean-Christophe GiardOlivier LesouhaitierSylvie ChevalierJean-Michel BrunelCécile MullerEmmanuelle DéPublished in: Antibiotics (Basel, Switzerland) (2023)
The emergence of multi-drug resistant pathogens is a major public health problem, leading us to rethink and innovate our bacterial control strategies. Here, we explore the antibiofilm and antivirulence activities of nineteen 6-polyaminosterol derivatives (squalamine-based), presenting a modulation of their polyamine side chain on four major pathogens, i.e., carbapenem-resistant A. baumannii (CRAB) and P. aeruginosa (CRPA), methicillin-resistant S. aureus (MRSA), and vancomycin-resistant E. faecium (VRE) strains. We screened the effect of these derivatives on biofilm formation and eradication. Derivatives 4e (for CRAB, VRE, and MRSA) and 4f (for all the strains) were the most potent ones and displayed activities as good as those of conventional antibiotics. We also identified 11 compounds able to decrease by more than 40% the production of pyocyanin, a major virulence factor of P. aeruginosa . We demonstrated that 4f treatment acts against bacterial infections in Galleria mellonella and significantly prolonged larvae survival (from 50% to 80%) after 24 h of CRAB, VRE, and MRSA infections. As shown by proteomic studies, 4f triggered distinct cellular responses depending on the bacterial species but essentially linked to cell envelope. Its interesting antibiofilm and antivirulence properties make it a promising a candidate for use in therapeutics.
Keyphrases
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- biofilm formation
- drug resistant
- escherichia coli
- public health
- pseudomonas aeruginosa
- multidrug resistant
- gram negative
- structure activity relationship
- acinetobacter baumannii
- candida albicans
- small molecule
- stem cells
- single cell
- case report
- mesenchymal stem cells
- helicobacter pylori infection
- replacement therapy